Rekovelle 12 mcg

REKOVELLE 12 MCG is a subcutaneous solution containing follitropin delta, used for fertility treatments. This medication supports ovarian stimulation in assisted reproductive technology (ART).

REKOVELLE 12 MCG is primarily used in fertility treatments to stimulate the ovaries for assisted reproductive technology (ART). It contains follitropin delta, a hormone that helps in the development of follicles in the ovaries. This medication is often part of a broader fertility protocol, aiming to support ovulation and improve the chances of conception. Patients should consult their healthcare provider to understand the specific uses of REKOVELLE 12 MCG in their treatment plan.

Common effects of REKOVELLE 12 MCG may include mild injection site reactions, such as redness or swelling. Some users might experience headaches, abdominal discomfort, or mood changes. These effects vary among individuals and are generally mild. Severe reactions are rare but should be reported to a healthcare professional immediately.

REKOVELLE 12 MCG should be handled with care, ensuring proper storage and administration as directed. It is crucial to follow the prescribed dosage and administration schedule. Patients with a history of ovarian hyperstimulation syndrome (OHSS) or other fertility-related conditions should inform their healthcare provider before use. Always use this medication under medical supervision.

REKOVELLE 12 MCG may interact with other medications, including those that affect hormone levels or fertility treatments. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of REKOVELLE 12 MCG, so it is advisable to discuss these with a healthcare professional.